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Abstract
Exposures to environmental toxicants and toxins cause epigenetic changes that likely play a role in
the development of diseases associated with exposure. The mechanism behind these exposure-
induced epigenetic changes is currently unknown. One commonality between most environmental
exposures is that they cause DNA damage either directly or through causing an increase in
reactive oxygen species, which can damage DNA. Like transcription, DNA damage repair must
occur in the context of chromatin requiring both histone modifications and ATP-dependent
chromatin remodeling. These chromatin changes aid in DNA damage accessibility and signaling.
Several proteins and complexes involved in epigenetic silencing during both development and
cancer have been found to be localized to sites of DNA damage. The chromatin-based response to
DNA damage is considered a transient event, with chromatin being restored to normal as DNA
damage repair is completed. However, in individuals chronically exposed to environmental
toxicants or with chronic inflammatory disease, repeated DNA damage-induced chromatin
rearrangement may ultimately lead to permanent epigenetic alterations. Understanding the
mechanism behind exposure-induced epigenetic changes will allow us to develop strategies to
prevent or reverse these changes. This review focuses on epigenetic changes and DNA damage
induced by environmental exposures, the chromatin changes that occur around sites of DNA
damage, and how these transient chromatin changes may lead to heritable epigenetic alterations at
sites of chronic exposure.
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Background
Epigenetics is the study of heritable gene expression changes that are not due to a change in
the DNA sequence. These changes can involve changes in DNA methylation, histone
modifications, and/or microRNA expression (reviewed in [Baylin and Jones 2011; Klaunig
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et al. 2011]). DNA methylation involves the addition of a methyl group to the cytosine of a
CpG dinucleotide pair. CpGs in intergenic and repetitive regions of the genome tend to be
highly DNA methylated. Environmental exposures and disease development have been
associated with loss of DNA methylation from these regions, which may cause reactivation
of transposable elements and re-expression of adjacent genes [Kulis and Esteller 2010; Hou
et al. 2012]. In contrast to repetitive DNA, about 60% of gene promoters contain dense
regions of CpGs, called CpG islands. DNA methylation of a CpG island causes
transcriptional repression of the associated gene and aberrant DNA methylation of these
islands has been highly studied in carcinogenesis [Baylin and Jones 2011].
In addition to DNA being modified to alter gene expression, histones can also be modified.
DNA in the nucleus of cells is wrapped around nucleosomes that are made up of histones.
Each histone has a histone tail that protrudes out of the nucleosome and can be post-
translationally modified at various residues in many different ways. These modifications are
called histone marks. Histone marks are either active marks allowing for open chromatin
and expression of the associated genes or repressive marks resulting in compact chromatin
and reduced expression of the associated genes [Baylin and Jones 2011]. Environmental
exposures have been associated with global and locus-specific changes in histone mark
levels [Cortessis et al. 2012; Hou et al. 2012].
The third epigenetic change involves microRNAs (miRNAs), which are a family of small
non-coding RNAs that modulate expression of other genes in a sequence specific manner by
binding to 3′-untranslated regions of target mRNAs (reviewed in [Di Leva et al. 2013]).
miRNAs are short single-stranded RNAs of approximately 20–24 nucleotides in length that
are transcribed from DNA but not translated into proteins. miRNAs negatively regulate
expression of target genes at the post-transcriptional level by binding to 3′-untranslated
regions of target mRNAs. The expression of miRNAs has been shown to change with
exposures to toxicants and at sites of inflammation [Cortessis et al. 2012; Hou et al. 2012;
Tili et al. 2013].
Exposure to environmental toxicants and toxins plays a role in the etiology of a diverse array
of diseases and can lead to epigenetic changes [Cortessis et al. 2012; Hou et al. 2012]. Since
by definition epigenetic changes heritably alter gene expression levels, it is thought that such
exposure-induced epigenetic alterations may play a direct role in disease formation and/or
progression. However, the mechanisms by which exposures cause epigenetic changes are
unclear. Exposures to toxicants and toxins can cause DNA damage either directly by the
parent compound, via the production of reactive intermediates, or through the generation of
reactive oxygen species (ROS) [Poirier 2004; Klaunig et al. 2011]. DNA damage plays a
known role in disease etiology through inducing mutation that leads to gain of function or
loss of function for key genes. The epigenetic changes discussed above also occur in a
transient manner during chromatin-based processes including DNA damage repair,
transcription, and DNA replication. However, these transient changes are not considered
true epigenetic changes unless they are stable and heritable, being passed on to daughter
cells during cell division. For the purpose of this review there is no delineation between
epigenetic changes that are permanent versus those that are heritable through a finite number
of cell divisions, but ultimately are reversible as both types of epigenetics changes could
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conceivably play roles in disease development. In this review, I will first discuss the types of
DNA damage and epigenetic changes associated with specific environmental exposures and
the chromatin changes that are associated with DNA damage repair. I will then discuss the
possibility that at least some epigenetic changes are initiated by normally transient
chromatin-based changes associated with DNA damage repair.
Environmental exposure-induced DNA damage
A common toxicity inflicted upon cells following environmental exposures is DNA damage.
DNA damage can occur directly by exposure to ionizing or ultraviolet (UV) radiation, which
ionize components of DNA and are absorbed directly by DNA bases, respectively.
Chemicals or their reactive intermediates can react with DNA to modify DNA bases, form
DNA adducts, and/or form DNA interstrand crosslinks [Poirier 2004]. Exposures can also
act through a mechanism by which elevated levels of ROS cause oxidative DNA damage.
ROS may be generated from the agent itself or from many sources in the cell including
xenobiotic metabolism, damaged mitochondria, or an immunologic response to the exposure
[Klaunig et al. 2011]. ROS are a set of reactive compounds including superoxide, the
hydroxyl radical, and hydrogen peroxide (H2O2). Increases in cellular ROS, whether
through physiological modification or through chemical exposure contribute to the process
of carcinogenesis [Klaunig et al. 2011]. Furthermore, environmental exposures can
indirectly cause genotoxcitiy through interference with the mitotic spindle, causing an
unbalanced nucleotide pool, interference with DNA damage repair processes, or allowing
for bypass of cell cycle checkpoints [Kirsch-Volders et al. 2003]. The above mechanisms of
DNA damage can result in single or double strand DNA breaks (DSBs) and base
modifications [Klaunig et al. 2011]. Below I briefly discuss both the epigenetic changes
associated with various environmental exposures, namely heavy metals, particulate matter
(PM), polycyclic aromatic hydrocarbons (PAH), other chemicals, and radiation, and the
DNA damage caused by these exposures.
Epigenetic changes resulting from exposure to heavy metals include global changes in DNA
methylation after exposure to arsenic, cadmium, and lead; arsenic, chromium, and nickel-
associated hyper and hypomethylation of key gene promoters; arsenic, chromium, and
nickel-associated changes in histone marks; and arsenic and cadium-induced changes in
miRNA expression [Cheng et al. 2012; Chervona and Costa 2012; Chervona et al. 2012].
These heavy metals, as well as beryllium, chromium, cobalt, and iron, are demonstrated
carcinogens [Bal and Kasprzak 2002]. There are many molecular mechanisms suggested for
the carcinogenicity of these metals. However, several of them, including cobalt, chromium,
copper, iron, and nickel, induce reactive oxygen species and/or high valence metal ions that
can act as catalytic centers for redox reactions that directly oxidize DNA [Bal and Kasprzak
2002]. Moreover, millions of people consume water contaminated by inorganic arsenic, an
environmental carcinogen, and the ROS produced by arsenic exposure is a key factor in
arsenic carcinogenicity [De Vizcaya-Ruiz et al. 2009; Chervona and Costa 2012]. Further
supporting the importance of ROS in arsenic exposure, several studies have demonstrated
that the use of antioxidants significantly reduces the toxic and genotoxic effects of arsenic
[Mandal et al. 2007; Mittal and Flora 2007].
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Another kind of environmental exposure widely implicated in human cardiovascular and
lung disease/carcinogenesis is PM, which can be found in air pollution. Exposure to PM
with a diameter of < 10 μm has been associated with decreased DNA methylation levels of
repetitive elements and global histone mark and miRNA expression changes in blood cells
[Hou et al. 2012; Motta et al. 2013]. In vivo and in vitro studies suggest that PM exposure
causes ROS production [Li et al. 2002; Li et al. 2003; Xia et al. 2004; Hou et al. 2010]. At
least in part, this ROS generation is by mechanisms that involve the mitochondria-regulated
death pathway and the generation of iron-derived free radicals [Upadhyay et al. 2003; Xia et
al. 2004].
PAHs are combustion-related environmental pollutants that are found at high levels in
charcoal broiled foods, cigarette smoke, and diesel exhaust and are known DNA damaging
agents. The PAH benzo[a]pyrene (BaP) is one of the most studied PAHs with a well
understood mechanism of action. BaP can be metabolized to form anti-BP-7,8-
dihydrodiol-9,10-epoxide (BPDE), a carcinogen that covalently binds to DNA causing DNA
damage that can lead to mutations. Other PAHs operate by similar mechanisms to cause
DNA damage and mutation [Luch and Baird 2010]. Additionally, PAH-metabolites can be
further converted to PAH o-quinones and diesel exhaust particles contain quinoid PAHs,
some of which are highly redox active compounds that participate in redox cycling resulting
in the generation of ROS [Park et al. 2006; Chung et al. 2008; Zhang et al. 2012]. In
children and workers exposed to PAHs, level of exposure positively correlates with levels of
DNA damage in the form of DNA strand breaks and levels of oxidative DNA damage
[Ruchirawat et al. 2007; Cavallo et al. 2009; Wang et al. 2010; Kuang et al. 2013]. PAH
exposure has also been associated with changes in both global and locus specific DNA
methylation levels, genome-wide lysine 9 histone H3 (K9H3) acetylation profiles, and
expression of miRNAs [Sadikovic et al. 2008; Pavanello et al. 2009; Halappanavar et al.
2011; Herbstman et al. 2012; Lizarraga et al. 2012; Alegria-Torres et al. 2013].
Another environmental toxicant known to cause epigenetic changes is bisphenol A (BPA), a
well-known endocrine-disrupting chemical that has received particular attention because of
its widespread use in food containers and its potential for reproductive effects. In a mouse
model, in utero exposure to BPA causes DNA methylation changes associated with
increased obesity and insulin resistance [Dolinoy et al. 2007]. BPA exposure also induces
changes in miRNA expression and global levels of trimethyl K27H3 [Avissar-Whiting et al.
2010; Doherty et al. 2010; Tilghman et al. 2012]. Results for the genotoxicity of BPA are
still inconclusive, but recent studies suggest that BPA exposure may induce DNA damage
accumulation in cells via oxidative stress [Tiwari et al. 2012; Wu et al. 2013].
Pesticides constitute a wide variety of chemicals including herbicides, insecticides, and
fungicides and exposure to them may cause acute and delayed health effects. Exposure to
many of these chemicals has been linked to epigenetic changes including DNA methylation,
histone modification, and miRNA expression changes (reviewed in [Collotta et al. 2013]). In
both pesticide factory and agriculture workers, exposure to pesticides has been demonstrated
to result in genomic DNA damage, which was evaluated either by using the comet assay or
the frequency of micronuclei, although the exact mechanism by which pesticide exposure
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induces DNA damage is unclear [Bhalli et al. 2006; Sailaja et al. 2006; Benedetti et al. 2013;
Khayat et al. 2013].
Benzene is widely used in chemical industry and is a component of cigarette smoke
associated with hematological disorders and cancer formation. Exposure to benzene is
associated with changes in DNA methylation, including global hypomethylation of DNA,
hypomethylation of repetitive elements, and hypermethylation of specific gene promoters
[Hou et al. 2012; Seow et al. 2012; Xing et al. 2013]. Benzene itself is not mutagenic, but
benzene is metabolized into toxic metabolites that cause an increase in intracellular
production of ROS resulting in oxidative DNA damage [Hiraku and Kawanishi 1996].
Exposure to ionizing radiation (IR) occurs through diagnostic and therapeutic medical
devices as well as background radiation, cosmic rays, radioactive waste, radon decay,
nuclear tests, and nuclear accidents. Exposure to IR can cause global DNA hypomethylation,
DNA methylation changes at specific loci, and changes in expression of the DNA
methyltransferases (DNMTs) both acutely and up to 14 days post-irradiation [Kuhmann et
al. 2011; Chaudhry and Omaruddin 2012; Antwih et al. 2013] (reviewed in [Kim et al.
2013]). IR exposure also induces phosphorylation of H2AX, a decrease in K20H4
trimethylation, and changes in miRNA expression [Pogribny et al. 2005; Aypar et al. 2011;
Metheetrairut and Slack 2013]. Interestingly, both single high dose and chronic low dose
whole-body irradiation can significantly alter global and site-specific DNA methylation in
mouse tissue [Pogribny et al. 2004; Koturbash et al. 2005; Bernal et al. 2013]. IR is a known
carcinogen that damages cellular components, including DNA in the form of single and
double strand breaks, base damage, and DNA crosslinks and also increases cellular ROS
levels [Klaunig et al. 2011].
UV radiation exposure through sunlight and artificial sources is a primary risk factor for
melanoma. Chronic exposure of the skin of mice to UVB radiation or of human
keratinocytes in culture to UVA radiation causes chromatin and DNA methylation changes
at specific gene promoters [Nandakumar et al. 2011; Chen et al. 2012]. miRNA expression
changes have also been demonstrated in mouse skin 24 hours after a single UVB exposure
[Xu et al. 2012b]. Exposure of skin to UV radiation induces oxidative stress, inflammation,
and DNA damage in the form of DNA photoproducts such as cyclobutane pyrimidine
dimers [Xu et al. 2012b].
In addition to directly causing increases in ROS and DNA damage, exposure to
environmental toxicants can induce acute and/or chronic inflammation. For example, PM
from tobacco smoke and air pollution is associated with chronic obstructive pulmonary
disease [Punturieri et al. 2009]. Such inflammation results in increased exposure to ROS.
Cells undergo oxidative stress when ROS levels exceed the cell’s ability to balance the
oxidative environment. In response to tissue injury caused by exposures, inflammatory cells
are activated and directed to the site of injury (reviewed in [Medzhitov 2008]). Chemokines
are released that attract specific leukocyte populations, including neutrophils, eosinophils,
and macrophages. These cells produce a variety of ROS and release them at sites of
inflammation. Inflammatory cells may also use cytokines to stimulate ROS production in
neighboring epithelial cells.
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Chronic inflammation has been associated with cancer-specific epigenetic changes.
Infection with Helicobacter pylori, a carcinogenic bacterium, causes changes in histone
modifications, global DNA hypomethylation, and DNA hypermethylation of specific genes
in the human gastric mucosa, including those that are DNA methylated and silenced in
human gastric cancer cells [Maekita et al. 2006; Ding et al. 2010; Ushijima and Hattori
2012]. H. pylori-mediated inflammation appears to play a key role in these epigenetic
changes [Hur et al. 2011]. In the intestine, some Polycomb Repressive Complex 2 (PRC2)
target genes, which are a set of genes that have a tendency to DNA methylated and silenced
in cancer, are subject to aberrant DNA methylation and decreases in K27H3 trimethylation
following chronic inflammation, both in inflamed tissue and tumors [Hahn et al. 2008].
Furthermore, murine infection with a toxigenic bacterium, enterotoxigenic Bacteriodies
fragilis, causes acute epigenetic changes in colonic epithelial cells harvested from the areas
of highest inflammation. Changes in polycomb group (PcG) protein recruitment have been
demonstrated at gene promoters known to become epigenetically silenced in colon cancer
[O’Hagan et al. 2011]. miRNA expression is also altered in inflammatory conditions both in
immune and epithelial cells and likely plays roles both in controlling chronic inflammation
and in promoting cancer development (reviewed in [Chiba et al. 2012]).
Most studies linking environmental exposures and/or inflammation to epigenetic changes
have focused on chronic or repetitive exposures. While there is evidence that acute exposure
to IR can cause persistent epigenetic changes, chronic low-dose exposures are more potent
inducers of lasting epigenetic changes [Kovalchuk et al. 2004; Koturbash et al. 2005].
Furthermore, in mouse a model of colitis, it has been demonstrated that chronic
inflammation, as opposed to treatment with a genotoxic agent only, is necessary for the
induction of DNA methylation changes also suggesting that most exposure-related
epigenetic changes occur through chronic exposure [Katsurano et al. 2012].
Transient chromatin-based changes at sites of DNA damage
DNA in the nucleus is packaged into chromatin, which is a barrier to DNA damage
recognition and repair. Compacted chromatin is refractory to full activation of the DNA
damage response and disruption of DNA integrity alone can cause a change in chromatin
structure that activates DNA damage signaling [Berkovich et al. 2007; Murga et al. 2007;
Soria et al. 2012]. In order for repair machinery to access sites of DNA damage chromatin
must undergo remodeling. In part this remodeling is done by ATP-dependent nucleosome
complexes removing and/or sliding nucleosomes out of the way (reviewed in [Smeenk and
van Attikum 2013]). The heterochromatin-associated proteins, HP1 and Kap-1, also
participate in the early response to DSBs in euchromatin, although their exact role in DNA
repair is still unclear [Luijsterburg et al. 2009; Baldeyron et al. 2011; Soria et al. 2012]. In
addition to the movement of nucleosomes, histones are also post-translationally modified at
sites of DNA damage to both aid in DNA damage signaling and the recruitment and
retention of DNA repair factors [Lukas et al. 2011b]. One of the most well studied histone
modifications that occurs in the chromatin surrounding sites of DNA damage is
phosphorylation of the histone variant H2AX. phospho-H2AX promotes the retention and
accumulation of DNA repair proteins as well as histone modifiers and chromatin remodelers
[Lukas et al. 2011b]. Beyond aiding in DNA damage accessibility and signaling, it has been
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hypothesized that chromatin modifiers are recruited to the sites of DNA damage to locally
inhibit transcription to prevent it from interfering with the repair process and/or DNA
damage signaling [Price and D’Andrea 2013].
Finally, after DNA damage repair is complete, the chromatin is restored by both
repositioning nucleosomes and returning the epigenetic code back to its original state. All of
these processes require chromatin-modifying enzymes found at sites of DNA damage.
Interestingly, many of these proteins and complexes, particularly those discussed below, are
also involved in stable epigenetic changes during development and in cancer bringing into
question whether the transient recruitment of these proteins during DNA damage repair can
be tied to stable disease-associated epigenetic alterations.
NuRD
The nucleosomes deacetylase and remodeling (NuRD) complex is a co-repressor complex
that is recruited to sites of DNA damage induced by UV light and IR [Chou et al. 2010;
Larsen et al. 2010; Polo et al. 2010; Smeenk et al. 2010]. A core component of NuRD is the
chromodomain-helicase-DNA-binding 4 (CHD4), a member of the SNF2 superfamily of
ATPases, which use ATP hydrolysis to move nucleosomes along DNA. NuRD also contains
the histone deacetylases, HDAC1 and HDAC2, making the complex capable of forming
repressive chromatin. NuRD has been found to be rapidly recruited to sites of DSBs by its
interaction with the ubiquitin liagse RNF (RING finger protein) 8. The chromatin-
remodeling activity of CHD4 is proposed to decondense the chromatin at the DNA damage
site, which stimulates the formation of ubiquitin conjugates by RNF8/RNF168 [Larsen et al.
2010; Luijsterburg et al. 2012; Smeenk et al. 2013]. This ubiquitylation is needed for
amplification of the DNA-damage repair signal and recruitment of DNA damage repair
proteins including BRCA1 (breast cancer early-onset 1). Loss of BRCA1 recruitment leads
to impaired DSB repair and activation of the G2/M checkpoint and increased IR sensitivity.
CHD4 also binds BRIT1, a key regulator of homologous recombination, and loss of CHD4
impairs the recruitment of BRIT1 to DNA damage again leading to a reduction in BRCA1
recruitment [Pan et al. 2012]. CHD4 has also been found to be recruited to sites of laser
microirradiation in a poly(ADP ribose) polymerase (PARP1) dependent manner [Chou et al.
2010; Polo et al. 2010]. PARP enzymes are activated by DSBs, single-strand breaks, and
DNA nicks and, by modifying target proteins with poly(ADP-ribose) chains at DNA damage
sites, play a role in the recruitment of DNA repair factors to lesions. CHD4 has been found
to directly bind PARylated proteins, including PARP1 itself, at DNA damage sites [Polo et
al. 2010].
Polycomb
PcG proteins were originally discovered as chromatin modifiers that control silencing of the
homeotic (Hox) genes during embryonic development in fruit flies (reviewed in [Aloia et al.
2013]). In mammals, PcG members are also important in development by regulating
expression of key genes in developmental pathways. The PcG proteins make up two main
Polycomb Repressive Complexes, PRC1 and PRC2. To initiate silencing, PRC2, which
contains the histone methyltransferase EZH2, trimethylates histone H3 at lysine 27. PRC1,
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which contains E3 ubiquitin ligases and BMI1 (B lymphoma Mo-MLV insertion region 1
homolog), is then recruited to sites of this mark and catalyzes the monoubiquitiylation of
K119H2A. While in fruit flies there are DNA motifs for the recruitment for PRC2, there are
not similar elements in mammals and it is currently unknown what recruits PRC2 to specific
promoters during development. PRC1 and PRC2 also play abnormal roles in cancer.
Members of both complexes, especially BMI1 and EZH2, are often over expressed in
cancers and are involved with aberrant repression of key tumor suppressor genes [Bracken
and Helin 2009].
Recent work has implicated both PRC1 and PRC2 in DNA damage repair mostly at DSBs.
Members of PRC1, including BMI1 and Ring1B, have been localized to sites of DSBs [Pan
et al. 1074; Chou et al. 2010; Ismail et al. 2010; Chagraoui et al. 2011; Ginjala et al. 2011;
Nacerddine et al. 2012]. For an extensive review of this work, see Vissers HA et al [Vissers
et al. 2012]. Interestingly, ubiquitylation of H2A on K119 also occurs at sites of DSB in a
similar manner as its role in chromatin repression during development [Ginjala et al. 2011].
Recruitment of these proteins and ubK119H2A appear to be early events in the DNA
damage repair process as they occur minutes after IR with timing similar to other DNA
damage response factors and their presence is sustained for several hours [Chou et al. 2010;
Ismail et al. 2010; Ginjala et al. 2011]. Although there are many ubiquitylation events
around the sites of DSBs, which cause some discrepancies between the findings of different
groups, it is likely that ubK119H2A is dependent on BMI1 as loss of Ring1B and BMI1
interfere with basal and induced monoubiquitylation at sites of DNA damage [Ginjala et al.
2011]. RNF8-RNF168 are responsible for other ubiquitylation events around DSBs,
specifically in the generation of K63-linked ubiquitin chains [Shanbhag et al. 2010]. The
interaction of these different ubiquitylation events is unclear including which lysine residues
of H2A and H2AX are modified by RNF8-RNF168 and how these ubiquitin chains affect
monoubiquitylation of K119H2A [Vissers et al. 2012]. Recent work using a small molecule
inhibitor of the E3 ubiquitin ligase activity of PRC1, but not RNF8 or RNF168, has
suggested that K119H2A monoubiquitylation is required for subsequent RNF8-RNF168-
mediated polyubiquitylation at sites of DNA damage [Ismail et al. 2013].
PRC2 members have also been found localized to sites of DNA damage, including after UV
light, H2O2, and endonuclease-induced DSBs [Hong et al. 2008; O’Hagan et al. 2008; Chou
et al. 2010; O’Hagan et al. 2011; Seiler et al. 2011; Wu et al. 2011; Campbell et al. 2013].
Localization of these proteins in many cases has correlated with an increase in the
3meK27H3 mark, suggesting recruitment of a functional PRC2 complex. However, the
exact function of PRC2 at sites of DSBs remains unclear. As mentioned, during
development PRC2 recruitment and activity precedes and is necessary for PRC1
recruitment. However, this may not be a requirement at sites of DNA damage. The
recruitment of PRC1 is a very early event in the DNA damage response and some groups
have demonstrated that PRC1 recruitment is not affected by knockdown of PRC2
constituents [Ismail et al. 2010]. If PRC1 does not require the 3meK27H3 mark for its
recruitment to DSBs, then the question remains as to how and why this recruitment is
different from what occurs during development.
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DNA methyltransferases
DNMTs methylate CpG dinucleotides of DNA and play a normal role in the silencing of
developmental genes and repetitive elements. However, in cancer DNMTs are involved in
aberrant silencing of 100s to 1000s of gene promoters [Baylin and Jones 2011]. While all of
these silencing events are likely not drivers of carcinogenesis, silencing of the promoters of
tumor suppressor genes such as MLH1 and p16 play a direct role. DNMT1 is called the
maintenance methyltransferase because it prefers methylating the second strand of
hemimethylated DNA and is located at DNA synthesis forks for this purpose.
While there is some discrepancy as to which or if all DNMTs are involved in DNA damage
repair, it is evident that at least some are. Several groups have demonstrated the presence of
DNMT1 at both endonuclease and laser-induced breaks [Mortusewicz et al. 2005; O’Hagan
et al. 2008; Ha et al. 2010]. DNMT1 is rapidly and transiently recruited to DSBs through its
interaction with proliferating cell nuclear antigen (PCNA) and checkpoint kinase 1 (CHK1)
and loss of DNMT1 appears to modulate the rate of repair [Ha et al. 2010]. Because this
recruitment appears to be early in the repair process, it is thought that DNMT1 may be
functioning in sensing or mobilizing the DNA damage repair response to sites of DNA
damage [Jin and Robertson 2013]. DNMT3B, a de novo DNMT, has also both been found at
endonuclease-induced DSBs [O’Hagan et al. 2008], although it was not found to be
localized to laser-induced breaks [Mortusewicz et al. 2005]. Groups have shown that DNA
damage associated with recruitment of DNMTs results in DNA methylation changes that
occur immediately after DNA damage or persist after DNA damage repair has been
completed [Cuozzo et al. 2007; O’Hagan et al. 2008; O’Hagan et al. 2011]. One possible
role of localization of DNMTs at sites of DNA damage may be that DNMT1 is functioning
as a scaffolding protein for the recruitment of other epigenetic proteins to sites of DNA
damage rather than playing a specific role in methylating DNA. The findings of several
groups support this hypothesis. First, the recruitment of DNMT1 to DSBs does not require
its catalytic activity, secondly, the DNMTs interact as part of large complex induced by
H2O2 treatment, and finally, DNMT1 can play a scaffolding role in silencing genes in cancer
cells [Ha et al. 2010; O’Hagan et al. 2011; Clements et al. 2012]. Further work needs to be
completed to clarify the role of DNMTs during DNA damage repair.
Histone acetylation and deacetylation
Histone acetylation is a mark that is added and removed by histone acetyl transferases
(HATs) and HDACs, respectively. Histone acetylation, unlike some other histone marks,
alters the structure and charge of lysine residues and therefore regulates chromatin structure
and function by modifying histone-DNA and histone-protein interactions, making histone
acetylation directly involved in the regulation of transcription [Gong and Miller 2013]. The
HAT, 60 kDa Tat-interactive protein (Tip60) plays key roles in DSB repair by participating
in chromatin remodeling at DSBs as part of the NuA4 complex and by activating the ATM
kinase [Sun et al. 2010]. The NuA4-Tip60 complex binds to chromatin around sites of DSBs
and, p400, a remodeling ATPase that is part of the NuA4-Tip60 complex, exchanges H2A
for the histone variant H2AZ in nucleosomes at the DSB [Xu et al. 2010; Xu et al. 2012a].
Tip60 then acetylates histones H2AX and H4, which aids in the turnover of H2AX and
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modifies the chromatin architecture at break sites [Ikura et al. 2000; Downs et al. 2004;
Kusch et al. 2004; Murr et al. 2006; Robert et al. 2006; Ikura et al. 2007; Jha et al. 2008].
Interestingly, recently it has been demonstrated that by modulating histone acetylation
TIP60 promotes homologous recombination, while inhibiting nonhomologous end joining
[Hsiao and Mizzen 2013; Tang et al. 2013]. The HATs, GCN5, p300, and CBP have also
been implicated in DNA damage repair of DSBs and UV lesions [Tini et al. 2002; Kim et al.
2009; Vempati et al. 2010; Guo et al. 2011; Ogiwara et al. 2011].
The most studied HDAC in terms of DNA damage repair is sirtuin1 (SIRT1). In yeast, the
SIRT1 homolog relocalizes from telomeres to DSBs and is needed for efficient non-
homologous end joining [Tsukamoto et al. 1997; Martin et al. 1999; McAinsh et al. 1999;
Mills et al. 1999]. SIRT1 also localizes to sites of DNA damage in mammalian cells and has
been implicated in deacetylation of histones at sites of DNA damage as well as deacetylation
of DNA repair proteins and other proteins involved in the DNA damage response [Jeong et
al. 2007; Yuan and Seto 2007; Li et al. 2008; O’Hagan et al. 2008; Fan and Luo 2010]. Such
deacetylation of histones would result in more compacted chromatin, whereas deacetylation
of proteins has been shown to change their activity level. SIRT1 also interacts with Tip60 to
negatively regulate Tip60-mediated acetylation of H2AX [Yamagata and Kitabayashi 2009].
HDAC1 and HDAC2 have also been implicated in DNA damage repair [Miller et al. 2010;
Polo et al. 2010]. HDAC1 and HDAC2 have been shown to associate with many other
epigenetic proteins as part of the NuRD complex and with the DNMTs [Zhang et al. 1999;
Fuks et al. 2000]. Therefore, it is possible that they are being recruited to sites of DNA
damage as part of these complexes. Further studies are required to define how the
deacetylation of histones affects the other functions of these complexes.
Both increases and decreases of histone acetylation have been associated with DNA damage
repair, likely because DNA damage repair is dynamic process that requires both the opening
and closing of chromatin and there are several different histone tail lysines that can be
acetylated [Tamburini and Tyler 2005]. It has been difficult to determine the exact
relationship between the acetylation/deacetylation dynamics at sites of DNA damage
because most studies use chromatin immunoprecipitation (ChIP) assays to look at changes
in histone marks. These assays are only capable of resolving the locations of the modified
histones based on the size of the sonicated DNA fragments (typically 200 to 1000 bp).
Acetylation and deacetylation events may be very specific in terms of the distance to the
break site, with acetylation happening near the break and deacetylation occurring a few
nucleosomes away, or they may differ in timing, with acetylation occurring right after DNA
damage followed by deacetylation when DNA damage repair is completed. Further work
needs to be done to understand the exact relationship between histone acetylation and
deacetylation at sites of DNA damage.
Non-coding RNAs
The newest type of epigenetic modulators to be studied are non-coding RNAs, with
miRNAs being the most studied of this group. miRNAs post-transcriptionally regulate the
expression of target genes, have also been found to be involved in the DNA damage
response, and, as discussed above, their expression can be altered by environmental
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exposures (reviewed in [Chowdhury et al. 2012]). The set of miRNAs that change in
expression in response to DNA damage depends both on the cell type and on the damaging
agent used and can play a role in DNA damage signaling as well as DNA damage repair.
Overall their role in the DNA damage response is still poorly understood, but some
examples are provided. DNA repair and signaling proteins including ATM, H2AX, BRCA1,
and p53 can be directly inhibited by miRNAs [Sharma and Misteli 2013]. Irradiation results
in the downregulation of miR-335, a miRNA that targets CtIP, a protein involved in end
resection during homologous recombination, and therefore influences the selection of
homologous repair for the DNA repair of DSBs [Martin et al. 2013]. miRNA-7 is a negative
regulator of SET8 (SET domain containing 8), a H4K20 monomethyltransferase that plays a
role in DNA repair [Yu et al. 2013]. Loss of miRNA-7 promotes spontaneous DNA damage
and sensitizes cells to induced DNA damage. Recent studies suggest that another class of
small RNAs, called DSB-induced small RNAs (diRNAs), are induced around DSB sites and
promote DNA damage repair [Francia et al. 2012; Wei et al. 2012]. The exact function of
these diRNAs is unclear, however, one theory is that they may help generate either an open
or closed chromatin structure at the break site [Ohsawa et al. 2013]. Because there is no
evidence that changes in miRNA expression alter the chromatin directly at the site of DNA
damage and because little is known at this point about diRNAs, they will have to be a topic
for a future review.
Combination of chromatin-based changes at sites of DNA damage
While above the various chromatin modifying proteins and histone mark changes are
discussed separately, it is likely that they are acting together or sequentially during the repair
of damaged DNA. Several of the proteins are known to interact with each other including
the HDACs interacting with NuRD and DNMT1 as discussed [Zhang et al. 1999; Fuks et al.
2000], PcG members interacting with DNMTs [Vire et al. 2006], and SIRT1 interacting with
DNMTs and PcG proteins [Kuzmichev et al. 2005; Espada et al. 2007; O’Hagan et al. 2011].
Therefore, these proteins may be recruited to sites of DNA damage as part of larger
complexes that are capable of modifying histones and other proteins in several different
ways. Multiple histone modifications have been demonstrated to also occur in the chromatin
surrounding DNA damage and in some cases multiple modifications are required for the
recruitment of proteins involved in the DNA damage repair process. For example, 53BP1, a
chromatin-associated factor that promotes DSB repair by non-homologous end joining,
needs histones to be modified by both methylation and ubiquitylation for its proper binding
to nucleosomes [Fradet-Turcotte et al. 2013].
Inhibition of transcription and DNA damage repair
Both transcription and the DNA damage repair process are intimately involved with
chromatin changes. Certain DNA lesions and/or DNA repair processes, including high levels
of oxidative stress, result in inhibition of transcription on a global level [Berthiaume et al.
2006]. RNA polymerases (RNAPs) are stalled at bulky DNA lesions reducing levels of
transcription and, during transcription coupled DNA damage repair, they become
ubiquitylated and undergo proteasome-mediated degradation [Pankotai et al. 2012]. Stalled
elongating RNAPII provides a recognition signal for chromatin remodeling and recruitment
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of proteins involved in DNA damage repair [Fousteri et al. 2006]. Even though ionizing
radiation does not reduce transcription on a global level, it has been demonstrated that the
induction of DSBs specifically causes a reduction in activity of both RNAPI and RNAPII
and, in the case of RNAPII a reduction of transcription of the associated gene [Kruhlak et al.
2007; Shanbhag et al. 2010; Pankotai et al. 2012]. As DNA damage repair is completed both
global and local transcription return to normal.
The epigenetic proteins and complexes discussed here are all involved in both
transcriptional silencing during development and aberrant silencing in cancer [Baylin and
Jones 2011]. As discussed above, these proteins are also recruited to sites of DNA damage,
which suggests that they may play a role in preventing transcription at sites of DNA
damage, likely to prevent transcription from interfering with the DNA damage repair
process [Chou et al. 2010; Miller et al. 2010; Lukas et al. 2011b; O’Hagan et al. 2011]. In
BMI1 knockout mouse embryonic fibroblasts elongating RNAPII is maintained at DNA
damage foci, where as RNAPII is normally lost from these sites, suggesting that BMI1
recruitment is indeed playing a role in reducing transcription at sites of DNA damage
[Chagraoui et al. 2011]. Unlike epigenetic silencing during development and disease
formation, this DNA damage repair-associated inhibition of transcription is likely a transient
event that resumes once DNA damage repair is completed.
In order to prove these hypotheses, models must be developed to examine both transcription
and DNA damage repair at known locations in the genome over a given time period. One
such system could be one which utilizes the endonuclease assay developed by Shanbhag and
Greenberg [Shanbhag and Greenberg 2013].
DNA damage and heritable epigenetic alterations
The involvement of epigenetic silencing proteins in DNA damage repair is most likely a
normal part of the DNA damage repair process that causes transient changes in chromatin
compaction and transcription, which are restored to normal when DNA damage repair is
completed [Soria et al. 2012]. However, if these epigenetic players are not removed
correctly during the DNA damage repair process or if in the setting of chronic inflammation
or chronic toxicant exposure, there is repetitive DNA damage, these epigenetic changes may
result in aberrant permanent silencing of the gene. Aberrant DNA hypermethylation of CpG
islands, including promoter CpG islands commonly found DNA hypermethylated in cancer,
is observed at sites of chronic inflammation, including chronic biliary tract inflammation,
Barrett’s esophagus, H. pylori infection, and inflammatory bowel disease [Niwa and
Ushijima 2010]. Global DNA hypomethylation and a decrease in DNA methylation at
specific repetitive DNA sequences, similar to what is seen in cancers, have also been
observed in chronically inflamed tissue. Oxidative stress has been shown to induce the
formation of an epigenetic silencing complex that includes the DNMTs, SIRT1 and PRC2
members [O’Hagan et al. 2011]. This complex is enriched at GC-rich areas of the genome,
including CpG islands that become DNA hypermethylated and silenced in cancer. After
oxidative damage, these regions gain repressive histone modifications and have reduced
transcription of the associated genes, and in the case of low basal expression genes, gain
DNA methylation. Similar findings were demonstrated in inflamed tissue using a mouse
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model of colitis [O’Hagan et al. 2011]. This work led to the hypothesis that in settings of
chronic oxidative stress, such changes may persist and become permanent epigenetic
changes. Interestingly, it has been hypothesized that transcription protects gene promoters
from epigenetic silencing, suggesting that even a transient inhibition of transcription during
DNA damage repair may make promoters more susceptible to stable silencing [Thomson et
al. 2010]. However, a direct link between inflammation and stable DNA methylation
changes has not yet been established.
Recent whole-cell based studies suggest that DSBs themselves or chromatin modifications
that are associated with DSBs can at least persist through one cellular generation. DSBs that
occur during mitosis persist through mitosis as indicated by foci of DNA repair proteins and
are passed on symmetrically to daughter cells as 53BP1 (a DNA damage response protein)
nuclear bodies [Giunta et al. 2010; Lukas et al. 2011a]. However, whether successful DNA
damage repair of such DSBs occurs and/or the cells survive needs to be demonstrated.
Furthermore, exposure of mice to protracted low-dose radiation causes persistent 53BP1 foci
in epidermal stem cells that do not colocalize with other DNA repair proteins [Schanz et al.
2012]. The authors suggest that these 53BP1 foci may be permanent chromatin
rearrangements caused by the DNA damage repair of radiation-induced DSBs. While
chromatin changes need to be more closely examined in this system, this work does suggest
that chromatin surrounding a DSB may not always be restored back to normal after DNA
damage repair is completed and the altered chromatin can persist for an undetermined
amount of time.
While there is still not direct evidence that DNA damage can cause heritable epigenetic
changes, several experimental approaches have been utilized to determine if there is a link
between DNA damage and stable epigenetic changes. Cuzzo et al. demonstrated that an
endonuclease-induced DSB that is repaired by homologous recombination results in
sustained DNA methylation and transcriptional silencing of the associated gene [Cuozzo et
al. 2007] and the activity of DNMT1 in this process seems to be regulated by GADD45alpha
[Lee et al. 2012]. Exposure of cells to the ROS, H2O2, results in the redistribution of SIRT1
away from its normal binding sites in the genome to sites of DNA damage, which results in
a derepression of SIRT1-regulated genes that mimics transcriptional changes seen in aging
cells [Oberdoerffer et al. 2008]. In another approach, an endonuclease was used to induce a
DSB in the CpG island of an exogenously introduced copy of the E-cadherin promoter,
which is a promoter that is frequently DNA hypermethylated in epithelial cancers, including
the breast cancer cell line used for these studies, MB-MDA-231. The introduced promoter
drives expression of the herpes simplex virus gene, thymidine kinase (HSVTK), allowing
for negative selection for expression using the drug ganciclovir. Induction of the DSB
causes epigenetic silencing of the promoter without causing DNA mutation in a small
percentage of cells [O’Hagan et al. 2008]. The epigenetic silencing coincides with a gain in
promoter DNA methylation that increases with passage. However, DNA methylation does
not appear necessary for the DNA-damage induced epigenetic silencing as knockdown of
SIRT1 during the acute phase of DNA damage induction does not affect silencing of the
promoter, but does result in a loss of transient enrichment of DNMT3B at the break site and
a loss of DNA methylation in the silenced promoters. These studies suggest that at least in
experimental systems DNA damage can induce epigenetic changes. Further studies are
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required to extend these findings to in vivo settings involving environmental exposures and
disease developmental to establish firmly if there are direct links between exposure, DNA
damage, epigenetic changes, and disease formation.
Conclusions
It is evident that environmental exposures result in stable epigenetic changes. However, the
mechanisms of how exposures result in epigenetic alterations are unclear. It is likely that
exposures induce epigenetic alterations by more than one mechanism, possibly varying with
the specific exposure or tissue being studied. One hypothesis for such a mechanism is driven
by known chromatin changes that occur at sites of DNA damage. Many environmental
exposures cause an increase in DNA damage in cells either directly or through an increase in
ROS. At sites of DNA damage there are many chromatin changes including modifications of
histones and repositioning and/or removal of nucleosomes. Additionally, several proteins
known to be involved in aberrant epigenetic silencing in cancer, including the NuRD
complex, PcG proteins, and the DNMTs, have been localized to sites of DNA damage
(Figure 1). These proteins may play a role in inhibiting transcription during the DNA
damage repair process. Likely these chromatin changes are transient such that the chromatin
is restored back to normal after DNA damage repair is complete. However, at sites of
chronic exposure and/or inflammation repeated DNA damage and chromatin rearrangement
may occasionally result in aberrant restoration of the chromatin and cause stable epigenetic
alterations (Figure 1). If such epigenetic changes result in a survival or proliferative
advantage for the cell, they may persist in the cell population. Such a hypothesis is similar in
thought to the occasional DNA mutation that escapes proper DNA damage repair and results
in activation or repression of an oncogene or tumor suppressor gene, respectively. However,
the potential to reverse epigenetic changes after silencing occurs has raised great interest in
epigenetic-based therapeutics in the cancer field [Helin and Dhanak 2013]. At this point the
published work linking chromatin changes at sites of DNA damage to heritable epigenetic
changes is mostly circumstantial and more work needs to be done to demonstrate a direct
causative link between the two. Additionally, further work needs to be done to determine
other mechanisms by which environmental exposure can induce epigenetic changes.
Understanding the mechanisms behind exposure-induced epigenetic changes will hopefully
result in the development of biomarkers for exposure in order to better protect the health of
our population and possible drug treatments for at-risk populations either undergoing
chronic exposure to environmental pollutants or chronic inflammation.
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Figure 1. Model for how environmental exposure-induced DNA damage may lead to epigenetic
silencing
At sites of environmental exposure, either the exposure itself or increased levels of ROS
caused by exposure cause DNA damage (red star). At the sites of damage histone
modifications occur (green circles) and the chromatin is remodeled. Additionally, epigenetic
silencing proteins are recruited to the site of damage, possibly to prevent transcription from
interfering with the repair process. It is unclear at this time if all of these proteins are being
recruited to all sites of damage and whether or not they are interacting with each other. In
most instances, after completion of DNA repair the chromatin is restored back to normal, the
epigenetic silencing proteins are no longer localized to the area, and transcription resumes.
In cases of chronic exposure, DNA damage and repair cycles can happen repeatedly and, in
rare instances, the chromatin structure may not be returned to normal and binding of the
epigenetic silencing proteins may persist, resulting in stable epigenetic silencing.
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